If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPMR.L Regulatory News (PMR)

  • There is currently no data for PMR

Director/PDMR Shareholding

26 Jun 2012 13:48

26 June 2012

Panmure Gordon & Co. plc

Director shareholdings

Panmure Gordon & Co. plc ("the Company") announces that directors of the Company have today purchased ordinary shares of 4p each in the Company at a price of 9.5p as follows.

Director Shares purchased Resulting total beneficial holding Percentage of issued share capital
Anthony Cann 314,000 510,962 0.34%
Tim Linacre* 52,000 191,240 0.13%
Ed Warner 100,000 400,000 0.27%
Lesley Watkins 83,500 83,500 0.06%

In addition, Philip Tansey, Chief Financial Officer, and Tim Linacre, Chairman of Investment Banking, have today been granted share awards under the Company's Performance Share Plan over a total of 3,135,000 and 3,375,000 of the Company's ordinary shares respectively.

An amount of up to one-third of Philip Tansey's award will vest in each of 2015, 2016 and 2017 and an amount of up to one-third of Tim Linacre's award will vest in each of 2014, 2016 and 2017 if the Panmure Gordon Group achieves the following pre-tax profit levels in the financial years ending 31 December 2013, 2014 and 2015:

Financial year Pre-tax profit Number of shares to vest - Tim Linacre Number of shares to vest - Philip Tansey
2013 Less than £3m 0 0
2013 £3m - £4.5m 375,000 295,000
2013 £4.5m - £6m 750,000 670,000
2013 More than £6m 1,125,000 1,045,000
2014 Less than £4.5m 0 0
2014 £4.5m - £6m 375,000 295,000
2014 £6m - £7.5m 750,000 670,000
2014 More than £7.5m 1,125,000 1,045,000
2015 Less than £6m 0 0
2015 £6m - £7.5m 375,000 295,000
2015 £7.5m - £9m 750,000 670,000
2015 More than £9m 1,125,000 1,045,000

* Tim Linacre also has an option over 2,472,738 shares held in the Panmure Gordon & Co. plc No 2 Employee Benefit Trust which are currently exercisable and over which he is able to exercise voting rights, which when aggregated with his existing shareholding represents 1.77% of the Company's issued share capital. He also holds 872,731 performance share options which are currently exercisable. All of these options are at an exercise price of 4p and have no expiry date. He additionally holds 73,170 share options under the Company's Approved Company Share Option Plan at an exercise price of 41p, exercisable between 26 May 2013 and 26 May 2020.

Philip Tansey's beneficial holding in the Company's shares is 80,000 ordinary shares, representing 0.05% of the Company's issued share capital. In addition Mr Tansey has an option over 400,000 shares at an exercise price of 4p held in the Panmure Gordon & Co. plc No 2 Employee Benefit Trust which are currently exercisable and over which he is able to exercise voting rights, which when aggregated with his existing holding represents 0.32% of the Company's issued share capital. He also holds an award under the Performance Share Plan in respect of a further 320,000 shares which will automatically vest in equal quarters on 31 March 2013, 2014, 2015 and 2016, subject to continued employment with a group company.

Enquiries:

Sarah Wigley
Company Secretary 020 7459 3600
Gerry Beaney/Jen Hatter/Salmaan Khawaja
Grant Thornton Corporate Finance (Nominated Adviser) 020 7383 5100

Billy Clegg/Ed Gascoigne-Pees

FTI Consulting 020 7831 3113

Copyright Business Wire 2012

Date   Source Headline
3rd May 20169:41 amRNSAppointment of Non-Executive Chairman
25th Apr 20161:58 pmBUSNotice of AGM
21st Apr 20162:54 pmBUSHolding(s) in Company
21st Apr 20161:05 pmBUSHolding(s) in Company
14th Apr 201611:07 amBUSEBT trading plan
5th Apr 201612:55 pmBUSFinal Results
31st Mar 20163:12 pmBUSHolding(s) in Company
31st Mar 20167:00 amRNSFinal Results
17th Mar 201611:39 amBUSHolding(s) in Company
24th Feb 20167:17 amRNSBoard Change and Shareholder Financing
17th Feb 20167:00 amRNSDirectorate change
3rd Feb 201611:06 amBUSHolding(s) in Company
1st Feb 20162:13 pmBUSDirectorate Change
11th Jan 20161:56 pmBUSHolding(s) in Company
23rd Dec 20157:00 amRNSTrading Update
9th Dec 20157:00 amBUSHolding(s) in Company
4th Nov 20153:09 pmBUSHolding(s) in Company
23rd Oct 20152:06 pmBUSEBT trading plan - Replacement
22nd Oct 20156:04 pmBUSEBT Trading Plan
19th Oct 201511:59 amRNSForm 8.3 - Zwanziger Family Ventures LLC
7th Oct 20153:55 pmBUSHolding(s) in Company
1st Oct 20155:04 pmRNSForm 8.3 - EKF Diagnostics Holdings PLC
30th Sep 20154:37 pmBUSHolding(s) in Company
29th Sep 20157:00 amBUSHalf-yearly Report
9th Sep 201511:57 amBUSHolding(s) in Company
28th Aug 201510:46 amRNSForm 8.3 - EKF Diagnostics Holdings plc
27th Aug 20151:22 pmRNSForm 8.3 - EKF Diagnostics Holdings plc
26th Aug 20154:27 pmRNSForm 8.3 - EKF Diagnostics Holdings plc
26th Aug 20154:27 pmRNSForm 8.3 - EKF Diagnostics Holdings plc
10th Aug 201511:47 amBUSHolding(s) in Company
15th Jul 20158:19 amBUSAcquisition
8th Jul 201510:20 amBUSHolding(s) in Company
17th Jun 20154:44 pmBUSAcquisition
8th Jun 20154:11 pmBUSHolding(s) in Company
20th May 20152:13 pmBUSHolding(s) in Company
18th May 20152:19 pmBUSResult of AGM
18th May 20157:00 amRNSAGM Statement
6th May 20153:00 pmBUSProposed Purchase of Charles Stanley Securities - Replacement
6th May 20152:11 pmBUSProposed Purchase of Charles Stanley Securities
23rd Apr 20152:33 pmBUSNotice of AGM
22nd Apr 20154:54 pmBUSHolding(s) in Company
20th Apr 20153:17 pmBUSEBT Trading Plan
9th Apr 20155:10 pmRNSDealings by Directors and PDMRs
2nd Apr 20151:18 pmRNSNotification Of Major Interest In Shares
27th Mar 20158:44 amBUSFinal Results
24th Mar 20153:28 pmBUSDividend Declaration Timetable Amendment
24th Mar 20159:41 amBUSDirectorate Change
24th Mar 20157:00 amBUSFinal Results
17th Mar 20157:00 amRNSNotification of Preliminary Results
13th Mar 20154:25 pmBUSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.